fda d.i.s.c.o. burst: approval of pepaxto (melphalan flufenamide) in combination with dexamethaso...
Published 7 months ago • 12 plays • Length 3:01
Download video MP4
Download video MP3
Similar videos
-
14:19
all about pepaxto (melphalan flufenamide) #myeloma
-
0:36
the recent expanded fda approval of cilta-cel and ide-cel into earlier lines of myeloma treatment
-
0:52
dr. martin on fda approval of denosumab in multiple myeloma
-
3:38
signs and symptoms of myeloma #myeloma
-
10:20
understanding multiple myeloma (multiple myeloma explained clearly)
-
11:41
multiple myeloma - signs and symptoms, pathophysiology, treatment
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
2:49
genomic changes induced by high-dose melphalan in myeloma
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
2:31
how important is the fda approval of once-weekly dosage of kyprolis for multiple myeloma patients?
-
4:06
dr. shah discusses data on ide-cel and melflufen, both granted priority review by fda
-
1:00
the recent fda approval of teclistamab for r/r multiple myeloma
-
1:34
dr. anderson on recent fda approvals in multiple myeloma
-
9:24
fda approvals in myeloma and head and neck cancer, and findings across several tumor types
-
0:45
fda approval of teclistamab for r/r multiple myeloma and the value of immunotherapies
-
38:18
melflufen for myeloma: a deep dive
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
7:49
fda approval sought in multiple myeloma, 2017 aacr annual meeting highlights, and more
-
12:53
fda approval in sclc, partial hold in myeloma trials, nccn guideline update in crc, and more
-
3:22
anchor: melphalan flufenamide in r/r myeloma
-
1:00:32
understanding the fda approved new drug, selinexor and its use in multiple myeloma
Clip.africa.com - Privacy-policy